Kathryn Horwitz

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology
Google:
"Kathryn Horwitz"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sartorius CA, Horwitz KB. (2020) Response to: Progesterone and breast cancer pathogenesis. Journal of Molecular Endocrinology
Horwitz KB, Sartorius CA. (2020) Progesterone and Progesterone Receptors in Breast Cancer: Past, Present, Future. Journal of Molecular Endocrinology
Brechbuhl HM, Barrett AS, Kopin E, et al. (2020) Fibroblast subtypes define a metastatic matrisome in breast cancer. Jci Insight
Abdel-Hafiz HA, Dudevoir ML, Perez D, et al. (2018) SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner. Diseases (Basel, Switzerland). 6
Abdel-Hafiz HA, Horwitz KB. (2015) Role of epigenetic modifications in luminal breast cancer. Epigenomics. 7: 847-62
Ogba N, Manning NG, Bliesner BS, et al. (2014) Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells. Breast Cancer Research : Bcr. 16: 489
Pinto MP, Dye WW, Jacobsen BM, et al. (2014) Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling. Bmc Cancer. 14: 735
Knox AJ, Scaling AL, Pinto MP, et al. (2014) Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease. Breast Cancer Research : Bcr. 16: 418
Abdel-Hafiz HA, Horwitz KB. (2014) Post-translational modifications of the progesterone receptors. The Journal of Steroid Biochemistry and Molecular Biology. 140: 80-9
Chan DC, Zhang Z, Zheng D, et al. (2014) Abstract 4836: Immune-tolerance due to aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs) on cancer cells and enhanced cancer-platelet interactions Cancer Research. 74: 4836-4836
See more...